RLY-2608
RLY-2608 is a selective mutant PI3Kα inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
608.91
Molecular Formula
C29H14ClF5N6O2
Notes
Research use only, not for human use.
Receptor
PI3K
CAS Number
2733573-94-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
33016-05141 2x 75 µg
Human ADP-ribosylation Factor 6 (ARF6) AssayLite™ Antibody (FITC Conjugate)
Ask
View Details 
